Global pressure ulcers treatment market is estimated to be valued at USD 5.54 Bn in 2024 and is expected to reach USD 8.34 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6% from 2024 to 2031.
Figure 1. Pressure Ulcers Treatment Market Share (%), By Region, 2024
Pressure ulcers, also known as bedsores or pressure sores, are a type of injury that breaks down the skin and underlying tissue. These usually develop as a result of prolonged pressure on the skin. Pressure ulcers can range in severity from non-blanchable erythema of intact skin to full-thickness tissue loss. Risk factors include old age, poor nutrition, diabetes, and incontinence among others. Growing aging population worldwide can increase the prevalence of pressure ulcers, and this. can boost demand for effective treatment and prevention options for pressure ulcers.
Market Dynamics:
Global pressure ulcers treatment market growth is driven by growing geriatric population worldwide who are more prone to developing pressure ulcers due to age-related declining mobility and health issues. Rising prevalence of obesity and chronic diseases like diabetes, that increases the risk of pressure ulcers, can also drive the market growth. However, high costs associated with advanced wound care dressings and therapies can hamper the market growth. Development of novel cost-effective treatment solutions can offer lucrative opportunities for market players. Strong pipeline of innovative products to improve wound healing and prevent complications can drive the pressure ulcers treatment market growth.
Key Features of the Study:
- This report provides in-depth analysis of the global pressure ulcers treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global pressure ulcers treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Smith & Nephew, Integra LifeSciences, Hill-Rom Services, Essity Aktiebolag, Cardinal Health, 3M Healthcare, B. Braun Melsungen, Coloplast Group, and ConvaTec.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global pressure ulcers treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pressure ulcers treatment market.
Detailed Segmentation-
- By Product Type
- Wound Care Dressings
- Active Wound Care Therapies
- Wound Care Devices
- By End User
- Hospitals
- Community Health Centres
- Homecare Centres
- Others
- Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Smith & Nephew PLC
- Integra LifeSciences Holding Corporation
- Baxter International Inc. (Hill-Rom Holdings Inc.)
- Molnlycke Health Care AB
- Cardinal Health
- Essity Aktiebolag
- 3M Company
- Braun Melsungen AG
- ConvaTec Group PLC
- Coloplast Group
- Hill-Rom Holdings, Inc.
- Medtronic plc
- Organogenesis Inc.
- Invacare Corporation
- Talley Group Ltd
- Permobil AB
- GF Health Products, Inc.